Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infant primary vaccination study of DTPa-IPV/Hib-MenC-TT + Prevenar versus Pediacel + Menjugate + Prevenar with Menitorix booster
2008-003741-87Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of diphtheria toxoid, tetanus toxoid, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, meningococcal group C tetanus toxoid conjugate vaccine, pneumococcal 7-valent conjugate vaccine, diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccine, Meningococcal group C polysaccharide conjugate vaccine and Hib-MenC-TT in diphtheria, Tetanus, pertussis and 4 more (2 arms), sponsored by GSK. Started Apr 2009; status: completed.
02
Drugs
diphtheria toxoid, tetanus toxoid, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, meningococcal group C tetanus toxoid conjugate vaccinepneumococcal 7-valent conjugate vaccinediphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccineMeningococcal group C polysaccharide conjugate vaccineHib-MenC-TT
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2008-003741-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003741-87.